Position history for BAKER BROS. ADVISORS LP's holdings in CYTOMX THERAPEUTICS INC.
BAKER BROS. ADVISORS LP holds 5M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $23.4M as of 2026-Q1. The position was increased (+17.1% shares). CTMX represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$23.4M
Current Shares
5M
Total Value Change
+$15.5M
Total Shares Change
+1.5M
Other major holders of CTMX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 5M |
+17.1% |
| $23.4M |
| 0.1% |
| $4.81 |
40 |
| 2025-Q4 | Unchanged | 4.3M | 0.0% | $18.1M | 0.1% | $4.16 | 0 |
| 2025-Q3 | Increased | 4.3M | +22.0% | $13.6M | 0.1% | $3.23 | 34 |
| 2025-Q2 | New | 3.5M | - | $7.9M | 0.1% | $2.25 | 38 |